Department of Neurology, The First People's Hospital of Wenling, Zhejiang Province, Wenling, 317500, China.
Department of Special Inspection Section, The First People's Hospital of Wenling, No. 333, Chuanan South Road, Chengxi StreetZhejiang Province, Wenling, 317500, China.
Neurotox Res. 2022 Dec;40(6):2221-2237. doi: 10.1007/s12640-022-00558-8. Epub 2022 Sep 12.
Parkinson disease is a neurodegenerative disorder distinguished by dopaminergic shortage in the striatum and the accumulation of α-synuclein neuronal aggregates in the brains of patients. Since, there is no accurate treatment available for Parkinson disease, researches are designed to alleviate the pathognomonic symptoms such as neuroinflammation, oxidative stress, mitochondrial dysfunction, and apoptosis. Accordingly, a number of compounds have been reported to inhibit these pathognomonic symptoms. In this study, we have assessed the neuroprotective potential of citronellol against 6-OHDA-induced neurotoxicity in SH-SY5Y cells. The results found that citronellol treatment effectively hindered the cell death caused by 6-OHDA and thereby maintaining the cell viability in SH-SY5Y cells at 50 µg/mL concentration. As expected, the citronellol treatment significantly reduced the 6-OHDA-induced secretion of inflammatory factors (IL-1β, IL-6, and TNF-α), which was obtained through ELISA technique. Similarly, citronellol hindered the 6-OHDA-induced oxidative stress by lowering the intracellular ROS and NO level and MDA leakage along with increased expression of SOD level in SH-SY5Y cells. The JC-1 staining showed that 6-OHDA increased the number of green fluorescent dots with ruptured mitochondrial membrane potential, while citronellol increased the amount of red fluorescent, showing the rescue potential against the 6-OHDA-induced mitochondrial dysfunction. Furthermore, citronellol hampered the 6-OHDA-induced apoptosis via the suppression of Bcl-2/Bax pathway. The western blotting results hypothesized that citronellol rescued SH-SY5Y cells from 6-OHDA-induced neurotoxicity via modulating ROS-NO, MAPK/ERK, and PI3K/Akt signaling pathways. However, further clinical trials are required to verify the anti-Parkinson efficacy.
帕金森病是一种神经退行性疾病,其特征是纹状体多巴胺能短缺和患者大脑中α-突触核蛋白神经元聚集的积累。由于目前尚无针对帕金森病的精确治疗方法,因此研究旨在缓解神经炎症、氧化应激、线粒体功能障碍和细胞凋亡等特征性症状。因此,已经报道了许多化合物可以抑制这些特征性症状。在这项研究中,我们评估了香茅醇对 SH-SY5Y 细胞中 6-OHDA 诱导的神经毒性的神经保护潜力。结果发现,香茅醇处理能有效阻止 6-OHDA 引起的细胞死亡,从而在 50μg/mL 浓度下维持 SH-SY5Y 细胞的细胞活力。正如预期的那样,香茅醇处理显著降低了 6-OHDA 诱导的炎症因子(IL-1β、IL-6 和 TNF-α)的分泌,这是通过 ELISA 技术获得的。同样,香茅醇通过降低细胞内 ROS 和 NO 水平以及 MDA 漏出,同时增加 SH-SY5Y 细胞中 SOD 水平来抑制 6-OHDA 诱导的氧化应激。JC-1 染色显示,6-OHDA 增加了具有破裂线粒体膜电位的绿色荧光点的数量,而香茅醇增加了红色荧光的数量,显示出对 6-OHDA 诱导的线粒体功能障碍的挽救潜力。此外,香茅醇通过抑制 Bcl-2/Bax 途径抑制 6-OHDA 诱导的细胞凋亡。Western blotting 结果假设,香茅醇通过调节 ROS-NO、MAPK/ERK 和 PI3K/Akt 信号通路来挽救 SH-SY5Y 细胞免受 6-OHDA 诱导的神经毒性。然而,需要进一步的临床试验来验证其抗帕金森病的疗效。